MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6)

Biochemical and Biophysical Research Communications

Volumn 445, Issue 1, 2014, Pages 151-156

  Liu, Dachuang ^a,b   Tao, Tao ^a   Xu, Bin ^a   Chen, Shuqiu ^a   Liu, Chunhui ^a   Zhang, Lei ^a   Lu, Kai ^a   Huang, Yeqing ^a   Jiang, Liang ^a   Zhang, Xiaowen ^a   Huang, Xiaoming ^a   Zhang, Lihua ^c   Han, Conghui ^b   Chen, Ming ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b XUZHOU CENTRAL HOSPITAL   (China)

^c AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Bcl xL; Castration resistant prostate cancer (CRPC); miR 361 5p; STAT6

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; MICRORNA; MICRORNA 361; PROTEIN BCL XL; SMALL INTERFERING RNA; STAT6 PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANDROGEN DEPENDENT PROSTATE CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CASTRATION RESISTANT PROSTATE CANCER; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

BCL-XL; CASTRATION-RESISTANT PROSTATE CANCER (CRPC); MIR-361-5P; STAT6;

3' UNTRANSLATED REGIONS; ANIMALS; BCL-X PROTEIN; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STAT6 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896706065     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.140     Document Type: Article

References (25)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J. Clin. 63 2013 11 30
2. E.M. Peyromaure, K. Mao, Y. Sun, S. Xia, N. Jiang, S. Zhang, G. Wang, Z. Liu, and B. Debré A comparative study of prostate cancer detection and management in China and in France Can. J. Urol. 16 2009 4472 4477
3. D. Shapiro, and B. Tareen Current and emerging treatments in the management of castration-resistant prostate cancer Expert Rev. Anticancer Ther. 12 2012 951 964
4. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
5. J. Shen, S.A. Stass, and F. Jiang MicroRNAs as potential biomarkers in human solid tumors Cancer Lett. 329 2013 125 136
6. J.J. Yu, and S.J. Xia Novel role of microRNAs in prostate cancer Chin. Med. J. (Engl.) 126 2013 2960 2964
7. Y. Pang, C.Y. Young, and H. Yuan MicroRNAs and prostate cancer Acta Biochim. Biophys. Sin. 42 2010 363 369
8. J. Szczyrba, E. Löprich, S. Wach, V. Jung, G. Unteregger, S. Barth, R. Grobholz, W. Wieland, R. Stöhr, A. Hartmann, B. Wullich, and F. Grässer The microRNA profile of prostate carcinoma obtained by deep sequencing Mol. Cancer Res. 8 2010 529 538
9. B. Xu, N. Wang, X. Wang, N. Tong, N. Shao, J. Tao, P. Li, X. Niu, N. Feng, L. Zhang, L. Hua, Z. Wang, and M. Chen MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer Prostate 72 2012 1171 1178
10. A. Kanitz, J. Imig, P.J. Dziunycz, A. Primorac, A. Galgano, G.F. Hofbauer, A.P. Gerber, and M. Detmar The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma PLoS One 7 2012 e49568
11. E.A. Afanasyeva, A. Hotz-Wagenblatt, K.H. Glatting, and F. Westermann New miRNAs cloned from neuroblastoma BMC Genomics 9 2008 52
12. A. Watahiki, Y. Wang, J. Morris, K. Dennis, H.M. O'Dwyer, M. Gleave, P.W. Gout, and Y. Wang MicroRNAs associated with metastatic prostate cancer PLoS One 6 2011 e24950
13. H.W. Khella, N.M. White, H. Faragalla, M. Gabril, M. Boazak, D. Dorian, B. Khalil, H. Antonios, T.T. Bao, M.D. Pasic, R.J. Honey, R. Stewart, K.T. Pace, G.A. Bjarnason, M.A. Jewett, and G.M. Yousef Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses Tumour Biol. 33 2012 131 140
14. M. Schubert, M. Spahn, S. Kneitz, C.J. Scholz, S. Joniau, P. Stroebel, H. Riedmiller, and B. Kneitz Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer PLoS One 8 2013 e65064
15. A. Natoli, R. Lüpertz, C. Merz, W.W. Müller, R. Köhler, P.H. Krammer, and M. Li-Weber Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs Int. J. Cancer 133 2013 1945 1954
16. B.J. Feldman, and D. Feldman The development of androgen independent prostate cancer Nat. Rev. Cancer 1 2001 34 45
17. M.D. Jansson, and A.H. Lund MicroRNA and cancer Mol. Oncol. 6 2012 590 610
18. T. Tao, Y. Wang, H. Luo, L. Yao, L. Wang, J. Wang, W. Yan, J. Zhang, H. Wang, Y. Shi, Y. Yin, T. Jiang, C. Kang, N. Liu, and Y. You Involvement of FOS-mediated miR-181b/miR-21 signalling in the progression of malignant gliomas Eur. J. Cancer 49 2013 3055 3063
19. X. Wu, X. Xi, Q. Yan, Z. Zhang, B. Cai, W. Lu, and X. Wan MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition Med. Oncol. 30 2013 751
20. K. Takeda, and S. Akira STAT family of transcription factors in cytokine-mediated biological responses Cytokine Growth Factor Rev. 11 2000 199 207
21. T. Bowman, R. Garcia, J. Turkson, and R. Jove STATs in oncogenesis Oncogene 19 2000 2474 2488
22. O. Ritz, C. Guiter, K. Dorsch, I. Dusanter-Fourt, S. Wegener, H. Jouault, P. Gaulard, F. Castellano, P. Möller, and K. Leroy STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-celllymphoma Leukemia 22 2008 2106 2110
23. Z. Ni, W. Lou, S.O. Lee, R. Dhir, F. DeMiguel, J.R. Grandis, and A.C. Gao Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma J. Urol. 167 2002 1859 1862
24. S. Das, C.P. Roth, L.M. Wasson, and J.K. Vishwanatha Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer Prostate 67 2007 1550 1564
25. S. Das, P. Shetty, M. Valapala, S. Dasgupta, Z. Gryczynski, and J.K. Vishwanatha Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells Biochemistry 49 2010 2216 2226